Navigating treatment decisions in NSCLC
Listen to a medical oncologist, a pathologist and an oncology nurse practitioner discuss the evolving treatment landscape and how treatment decisions need to take into account potential side effects.
The multidisciplinary team
Medical oncologist: Dr Alexander Drilon, USA
Pathologist: Prof. Keith Kerr, UK
Oncology nurse practitioner: Dr Marianne Davies, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Merck & Co Ltd, Turning Point Therapeutics, Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.